Milestone Pharmaceuticals (MIST) Expected to Announce Earnings on Wednesday
Market Beat·- Milestone Pharmaceuticals is anticipated to announce its Q2 2026 financial results on August 12, 2026, with analysts expecting earnings of -$0.18 per share and revenue of $0.8170 million. - The company previously reported a Q1 EPS of -$0.20 and $0.24 million in revenue, while its stock opened at $1.18 with a market capitalization of $146.29 million. - Institutional investors and hedge funds currently own 86.18 % of the stock, and the company holds a consensus average rating of Moderate Buy with an average price target of $7.25.